ArticleInfectious diseases and therapy2022

Efficacy and Safety of a Phytopharmaceutical Drug Derived from Cocculus hirsutus in Adults with Moderate COVID-19: a Phase 2, Open-label, Multicenter, Randomized Controlled Trial.

Sadhna Joglekar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.